JP2019536783A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019536783A5 JP2019536783A5 JP2019528632A JP2019528632A JP2019536783A5 JP 2019536783 A5 JP2019536783 A5 JP 2019536783A5 JP 2019528632 A JP2019528632 A JP 2019528632A JP 2019528632 A JP2019528632 A JP 2019528632A JP 2019536783 A5 JP2019536783 A5 JP 2019536783A5
- Authority
- JP
- Japan
- Prior art keywords
- tyrosine
- methyl
- cancer
- composition according
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022122538A JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/365,120 US20170080093A1 (en) | 2013-10-22 | 2016-11-30 | Tyrosine Derivatives And Compositions Comprising Them |
| US15/365,120 | 2016-11-30 | ||
| PCT/US2017/063865 WO2018102506A1 (en) | 2016-11-30 | 2017-11-30 | Tyrosine derivatives and compositions comprising them |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022122538A Division JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019536783A JP2019536783A (ja) | 2019-12-19 |
| JP2019536783A5 true JP2019536783A5 (enExample) | 2021-01-14 |
Family
ID=60703174
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019528632A Pending JP2019536783A (ja) | 2016-11-30 | 2017-11-30 | チロシン誘導体及びそれらを含む組成物 |
| JP2022122538A Withdrawn JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022122538A Withdrawn JP2022153587A (ja) | 2016-11-30 | 2022-08-01 | チロシン誘導体及びそれらを含む組成物 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3548086A1 (enExample) |
| JP (2) | JP2019536783A (enExample) |
| KR (1) | KR20190089191A (enExample) |
| CN (1) | CN110062633A (enExample) |
| AU (1) | AU2017368135A1 (enExample) |
| BR (1) | BR112019011033A2 (enExample) |
| CA (1) | CA3045110A1 (enExample) |
| EA (1) | EA201991305A1 (enExample) |
| IL (1) | IL266840A (enExample) |
| MX (1) | MX2019006326A (enExample) |
| PH (1) | PH12019501186A1 (enExample) |
| WO (1) | WO2018102506A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111743887A (zh) * | 2019-03-26 | 2020-10-09 | 深圳先进技术研究院 | α-甲基酪氨酸或其衍生物的用途 |
| CN114173578A (zh) | 2019-05-14 | 2022-03-11 | 迪美公司 | 用于治疗癌症的组合物和方法 |
| CA3157334A1 (en) * | 2019-11-07 | 2021-05-14 | Miguel Angel MOLINA-VILLA | Methods and compositions for use of growth factor antibodies in combination with non-tyrosine targeting kinase inhibitors |
| US20210220312A1 (en) * | 2020-01-17 | 2021-07-22 | Tyme, Inc. | Compositions And Methods For Modulating Cancer |
| US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI323662B (en) * | 2002-11-15 | 2010-04-21 | Telik Inc | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| EP1718145A4 (en) * | 2004-02-02 | 2012-03-07 | Biosight Ltd | CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS |
| WO2007120153A1 (en) * | 2006-04-19 | 2007-10-25 | The Board Of Regents Of The University Of Texas System | Compositions and methods for cellular imaging and therapy |
| CN104586832B (zh) * | 2007-09-10 | 2018-02-16 | 北京强新生物科技有限公司 | 用于癌症治疗的组合物和方法 |
| NZ628757A (en) * | 2012-01-17 | 2016-07-29 | Tyme Inc | Pharmaceutical compositions and methods for treating cancer |
| US9585841B2 (en) * | 2013-10-22 | 2017-03-07 | Tyme, Inc. | Tyrosine derivatives and compositions comprising them |
-
2017
- 2017-11-30 JP JP2019528632A patent/JP2019536783A/ja active Pending
- 2017-11-30 MX MX2019006326A patent/MX2019006326A/es unknown
- 2017-11-30 BR BR112019011033A patent/BR112019011033A2/pt not_active IP Right Cessation
- 2017-11-30 EP EP17817552.7A patent/EP3548086A1/en not_active Withdrawn
- 2017-11-30 AU AU2017368135A patent/AU2017368135A1/en not_active Abandoned
- 2017-11-30 WO PCT/US2017/063865 patent/WO2018102506A1/en not_active Ceased
- 2017-11-30 CA CA3045110A patent/CA3045110A1/en active Pending
- 2017-11-30 CN CN201780074235.7A patent/CN110062633A/zh active Pending
- 2017-11-30 EA EA201991305A patent/EA201991305A1/ru unknown
- 2017-11-30 KR KR1020197018473A patent/KR20190089191A/ko not_active Ceased
-
2019
- 2019-05-23 IL IL266840A patent/IL266840A/en unknown
- 2019-05-29 PH PH12019501186A patent/PH12019501186A1/en unknown
-
2022
- 2022-08-01 JP JP2022122538A patent/JP2022153587A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020130125A1 (ja) | 抗体−薬物コンジュゲートとキナーゼ阻害剤の組み合わせ | |
| JP2019501204A5 (enExample) | ||
| JP2019504100A5 (enExample) | ||
| JP2018533582A5 (enExample) | ||
| RU2014152107A (ru) | Комбинированная терапия с использованием антител к клаудину 18.2 для лечения рака | |
| WO2017151425A1 (en) | Hsp90 inhibitor drug conjugates | |
| JP2022510962A5 (enExample) | ||
| JP2006265245A5 (enExample) | ||
| JP2022551652A (ja) | 線維芽細胞増殖因子受容体シグナル伝達の調節不全を伴う癌の標的処置 | |
| RU2016127634A (ru) | Гетероциклические модуляторы синтеза липидов для применения против рака и вирусных инфекций | |
| WO2010086964A1 (ja) | がん治療のための併用療法 | |
| CN110478487A (zh) | 一种大环内酯化合物在逆转肿瘤多药耐药增强抗肿瘤疗效方面的应用 | |
| JP2022153587A (ja) | チロシン誘導体及びそれらを含む組成物 | |
| CA3149112A1 (en) | Novel therapeutic use | |
| KR102929813B1 (ko) | 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용 | |
| TW201309298A (zh) | 治療惡性神經膠質瘤之醫藥組合物 | |
| CN101715342A (zh) | 钴胺素紫杉烷生物结合物 | |
| JP2023517671A5 (enExample) | ||
| WO2022047400A1 (en) | 5'-substituted nucleoside monophosphates, prodrugs thereof, and uses related thereto | |
| US11110105B2 (en) | Compounds, composition and uses thereof for treating cancer | |
| AU2013233094A1 (en) | Novel antitumor agent comprising combination of three agents | |
| JP2009506019A (ja) | 癌治療のための組み合わせ | |
| CA3059270C (en) | Compounds, composition and uses thereof fortreating cancer | |
| JP2025128194A (ja) | 哺乳動物の身体におけるｍｙｃ発現腫瘍のタウロリジン治療 | |
| JP2022543021A5 (enExample) |